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Abstract
The prior immunisation of mice with purified excretory-secretory product (ESP) led to a complete failure of Giardia lamblia
colonisation following challenge inoculation of these animals with trophozoites. The prior immunisation of mice with ESP
resulted in a significant stimulation of local immunity as evidenced by a significant enhancement of T helper/inducer activity
along with a significant increase in immunoglobulin A-bearing cells. Further, the presence of anti-ESP antibodies in the serum
of immunised as well as immunised-challenged animals indicated the stimulation of the systemic lymphoid system. This
suggests that the ESP is highly immunogenic and it could be one of the major antigens of G. lamblia responsible for protection
against the infection. z 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Giardia lamblia has been implicated as one of the
causative agents of diarrhoea and malabsorption es-
pecially in children [1]. Identi¢cation of the parasite
antigen responsible for initiating protective immunity
is essential to complete our understanding of the
natural history of G. lamblia infection and the devel-
opment of an enteric vaccine. Several groups have
investigated the antigenic determinants of Giardia
[2^11]. These studies provide evidence that surface
molecules serve as anti-parasite targets for the host
immune system. However, the importance of these
antigens in promoting clearance of G. lamblia from
the intestine and the development of protective im-
munity remains to be established. The immune sys-
tem appears to have a pivotal role in not only a¡ect-
ing parasite clearance and protective immunity but
possibly also in the pathogenesis of the T cell-medi-
ated mucosal damage.
Since G. lamblia is primarily a gut parasite, alter-
ations of gut-associated immune e¡ector mechanisms
would be important in permitting G. lamblia troph-
ozoites to colonise while a stimulation of such re-
sponses would eliminate the parasite from the gut.
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The factors that mediate the clearance of G. lamblia
infection in some individuals while allowing persist-
ence of infection in others remain elusive. Current
evidence suggests that both humoral and cellular im-
mune responses are important in clearing the para-
site and providing immunity to reinfection [12^15].
Though the trophozoites of G. lamblia have a com-
plex mosaic of antigens, the surface-associated anti-
gens would be important for initiation of host im-
mune responses and activation of immunological
e¡ector mechanisms. Such responses may destroy
the parasites or inhibit their multiplication [16,17].
Therefore knowledge of the antigenic composition
of the parasite and the role that these antigens play
in the immune response during infection is important
for understanding the pathogenesis of the disease.
We have earlier identi¢ed and characterised an im-
munodominant excretory-secretory (ES) antigen
(ESP, 58 kDa) of G. lamblia (paper communicated:
Article No. IAI 1179-98) and the main aim of the
present study was to investigate the biological signif-
icance of this antigen in gut-associated e¡ector im-
mune responses leading to the clearance of the para-
site. This paper thus focuses its attention to the
immune responses developed against the puri¢ed
ES product of G. lamblia in an experimental mouse
model to understand the clearance of infection.
2. Materials and methods
2.1. Puri¢cation of ESP
Cell-free supernatants of G. lamblia collected after
12 h of culture in MEM were successively precipi-
tated with di¡erent percentage saturations of
(NH4)2SO4 and assessed for immunoreactivity by
micro-ELISA assay. The 25% and 40% saturated
(NH4)2SO4-precipitated ES fractions having maxi-
mum immunoreactivity with anti-CGE antibodies
were pooled, labelled as crude ES antigen (CESA),
which was successfully eluted out ¢rst from the anti-
CGE IgG-Sepharose CL-4B column and further
fractionated to homogeneity by gel ¢ltration using
Protein Pak SW 300 column in the FPLC system.
Both SDS-PAGE and alkaline PAGE of the puri¢ed
protein (labelled as ESP) revealed a single band of
Mr 58 kDa (Fig. 1).
2.2. Groups of animals
Inbred BALB/c mice aged 3^4 weeks (15^18 g) of
either sex maintained in the animal facility room of
our department were employed in the study. These
animals were checked for G. muris infection [18].
They were grouped (10 mice per group) as follows.
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Fig. 1. Characterisation of puri¢ed ESP. a: Molecular weight markers, i.e., phosphorylase b (97.4 kDa), bovine serum albumin (66 kDa),
glutamate dehydrogenase (55 kDa), pepsin (34.7 kDa) and lysozyme (14.2 kDa), CESA (10 Wg) and the puri¢ed ESP (5 Wg) were applied
in lanes A, B and C respectively in SDS-PAGE (10%). b: The molecular mass of the puri¢ed ESP was determined from the plot of rela-
tive electrophoretic mobility of the marker proteins against their corresponding molecular weights. c: The CESA (10 Wg) and the puri¢ed
ESP (7.5 Wg) were applied on alkaline PAGE (7.5%) in lanes A and B respectively.
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Group 1: immunised group. These mice received
four oral doses (50 Wg total) of puri¢ed ESP at in-
tervals of 7 days each, after neutralising the stomach
acidity with 0.25 ml NaHCO3 (100 mg ml31, pH
8.5). The antiserum from these animals was tested
by immunodi¡usion [19] using 1.5% agarose in 0.05
M sodium barbital bu¡er (pH 8.3), to assess to the
status of immunisation.
Group 2: immunised-challenged group. These an-
imals were immunised as described for group 1.
However, this group of animals was challenged
with G. lamblia trophozoites 7 days after the last
immunising dose.
Group 3: infected group. The animals of this
group were infected with G. lamblia trophozoites
after receiving NaHCO3 (as above).
Group 4: control group. These animals received
the same treatment of NaHCO3 (as above) prior to
receiving normal saline and served as control ani-
mals. This is to control for the e¡ect of bicarbonate
treatment on trophozoite infectivity.
2.3. Infection/challenge of the experimental animals
Axenic G. lamblia trophozoites (Portland-1 strain)
were harvested from 48^72-h culture and washed
with 0.15 M phosphate-bu¡ered saline, pH 7.2
(PBS). The count was adjusted to 2U107 viable
trophozoites per millilitre of PBS and the animals
were challenged intraoesophageally with 0.5 ml of
inoculum with a catheter [20].
2.4. Follow-up of animals
The animals from each group were killed at vari-
ous post immunisation/post challenge (PI/PC) or
post infection (p.i.) days, i.e., 3^5 days (establish-
ment phase), 9^11 days (acute phase) and 17^21
days (decline phase).
2.5. Trophozoite load in the intestine
The trophozoites were counted in the intestinal
perfusate of infected as well as immunised-challenged
animals by the method of Vasudeva et al. [21]. After
laparotomy, the small intestine was excised and
£ushed with a ¢xed volume of ice-cold normal saline.
The perfusate was centrifuged at 50Ug for 2^3 min
to remove the tissue fragments and food particles.
The supernatant was centrifuged at 600Ug for 10
min. The pellet was washed with normal saline and
the total number of trophozoites was counted in a
haemocytometer.
2.6. Isolation of gut lymphocytes
Intraepithelial lymphocytes (IEL) and lamina
propria lymphocytes (LPL) from control and exper-
imental mice were isolated by the modi¢ed method
of Davies and Parrot [22] and Tagliabue et al. [23].
Brie£y, a 12^15 cm long segment of the small in-
testine, cut longitudinally after surgical removal of
Peyer’s patches, was fragmented into 1^2 cm long
pieces. These pieces after washing in Hanks’ bal-
anced salt solution (HBSS) were incubated in
HBSS with 5 mM dithiothreitol (DTT) (Sisco, India)
for 5^10 min at room temperature to remove mucus.
The gut pieces incubated at 37‡C in Ca2,Mg2-free
HBSS with 1034 M EDTA for 20 min under con-
stant stirring were washed 3^4 times in Ca2,Mg2-
free HBSS containing 5% foetal calf serum (FCS), at
room temperature. The cells in the supernatant were
washed twice, suspended in RPMI 1640 medium
with 5% FCS and passed through a loosely packed
glass wool column (GWC). They were then subjected
to Ficoll Isopaque density gradient (Sigma Chemical
Co., USA) centrifugation. The cells at the interface
were harvested, washed and resuspended in RPMI
1640 medium with 10% FCS. These cells were la-
belled ‘IEL’.
The gut pieces after the complete recovery of
IEL were suspended in RPMI 1640 medium con-
taining 10% FCS and 20 U ml31 of collagenase
(type IV, Sigma Chemical Co., USA). The cell sus-
pension after incubation at 37‡C for 10 min was
passed through GWC before being subjected to
Ficoll Isopaque density gradient centrifugation. The
cells recovered at the interface were labelled
‘LPL’.
2.7. Preparation of lymphocytes from Peyer’s patches
(PP) and spleen
The lymphocytes from spleen and PP were isolated
by the method of Lycke et al. [24]. Brie£y, the lym-
phocytes from both tissue suspensions were collected
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separately by teasing them in HBSS between the
ends of a frosted slide and passed through GWC.
The resulting ¢ltrate was centrifuged at 250Ug for
10 min at 4‡C and the supernatant was discarded.
The washed cells of both populations were then sep-
arately subjected to Ficoll Isopaque gradient centri-
fugation. The cells at the interface of the gradient
were collected and ¢nally washed and suspended in
RPMI/FCS.
2.8. Cell viability
The viability of IEL, LPL as well as PP and spleen
lymphocytes was checked by the 0.2% trypan blue
exclusion procedure [25].
2.9. Enumeration of T cell subsets and assessment of
immunoglobulin bearing cells by £ow cytometry
[26]
Brie£y, the T/B cell markers on IEL, LPL, PP and
spleen lymphocytes were labelled by incubating the
individual cell preparations with FITC-labelled anti-
mouse Thy 1.2, L3T4 and Lyt 2.2 monoclonal anti-
bodies (Becton Dickinson, USA) as well as FITC-
labelled goat anti-mouse F(ab)2 IgG, IgA and IgM
(Kirkegaard and Perry, USA) for 30 min at room
temperature in the dark. After washing with PBS,
the cells were ¢xed with 0.5% formaldehyde at 4‡C
for 30 min and acquired on FACScan (Becton Dick-
inson, USA) to assess the percentage of £uorescent
cells.
2.10. Humoral immune response
The levels of anti-ESP antibodies in the serum
samples collected after completion of immunisation
as well as infection at various days after challenge in
all group of animals were checked by standard mi-
cro-ELISA assay [27].
2.11. Statistical analysis
The statistical analysis of data was done by em-
ploying one-way analysis of variance (ANOVA) with
multiple comparisons and only values 6 0.01 were
considered as signi¢cant. All values are expressed
as mean þ S.D.
3. Results and discussion
There has been much controversy in selecting a
suitable mode of immunisation to stimulate an e¡ec-
tive mucosal immunity. Parenteral immunisation has
been the main vaccination route for infectious dis-
eases. This route has been e¡ective in preventing in-
fectious diseases which have a systemic phase prior
to or concomitant with their major pathological ef-
fects. However, such a route of immunisation has
been at the best only marginally e¡ective in prevent-
ing gut-dwelling infections [28^30]. The failure of the
parenteral route of infection is obvious because the
parenteral antigen administration fails to induce mu-
cosal immunity [30]. However, the oral route has
been found to be very e¡ective at eliciting a speci¢c
mucosal immune response although it requires pro-
longed antigen administration in large amounts
[20,30,31]. The oral immunisation of experimental
animals with the puri¢ed ESP (as indicated by im-
munodi¡usion, Fig. 2) was indeed found to stimulate
the immune system very e⁄ciently. The introduction
of the ESP into the intestinal lumen also prevented
the establishment of the G. lamblia trophozoites in
the immunised-challenged group, whereas the infec-
tion established by 3^5 days p.i. in the intestine of
infected control animals (group 3), after reaching
peak levels at 9^11 days p.i., was spontaneously
cleared by 17^21 days p.i. (Fig. 3).
Studies by Ferguson et al. [32] proposed that the
mucosal T lymphocytes are likely to be involved in
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Fig. 2. Immunodi¡usion pattern of the test sera of ESP-immu-
nised mice. Wells 1, 2, 3 and 4 contain antisera from immunised
mice (group 1); well 5 contains preimmune sera; well 6 contains
the puri¢ed ESP.
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the immune reactions or in hypersensitivity reactions
to the parasite. The data of the present study indi-
cated that the immune responses at gut level during a
primary G. lamblia infection involved the interac-
tions of both intestine T cells and antibody-produc-
ing cells. The extraction of IEL and LPL using the
modi¢ed method of Davies and Parrot [22] and
Tagliabue et al. [23] produced high yields of both
IEL and LPL per animal (10.14 þ 1.6U106 and
12.15 þ 2.34U106 respectively) with s 90% viability.
FEMSIM 960 8-2-99
Table 1
Percentage of T cell subsets and immunoglobulin-containing cells in intraepithelium (IEL)
Group Days Total T CD4+ CD8+ IgG IgA IgM
(p.i. ;PI;
PI/PC)
(a) Control 3^5 42.64 þ 0.99 21.86 þ 1.08 66.98 þ 2.58 2.45 þ 0.11 0.62 þ 0.43 0.62 þ 0.09
9^11 43.56 þ 0.87 20.96 þ 1.04 67.63 þ 2.25 2.39 þ 0.23 0.61 þ 0.37 0.63 þ 0.13
17^21 41.60 þ 0.93 22.90 þ 1.06 68.89 þ 2.63 2.42 þ 0.17 0.63 þ 0.49 0.61 þ 0.08
(b) Infected 3^5 56.66 þ 1.07**a 18.93 þ 0.59**a 78.25 þ 0.33**a 1.60 þ 0.08 0.62 þ 0.05 5.21 þ 0.17a
9^11 80.27 þ 0.93**a 35.54 þ 0.94**a 78.56 þ 0.95**a 2.73 þ 0.18 0.37 þ 0.02 1.25 þ 0.13a
17^21 74.73 þ 0.93**a 27.51 þ 0.93**a 69.76 þ 0.80 9.84 þ 0.76**a 6.35 þ 0.14a 0.64 þ 0.44
(c) Immu-
nised
3^5 60.72 þ 1.06**a 35.29 þ 1.02**a 62.56 þ 0.93*a 3.83 þ 1.09 1.21 þ 0.08 0.47 þ 0.15
9^11 66.86 þ 0.95**a 38.67 þ 0.85**a 40.37 þ 1.18**a 7.72 þ 0.73**a 2.96 þ 0.43a 1.25 þ 0.10a
17^21 70.51 þ 1.04**a 49.88 þ 0.90**a 27.44 þ 0.92**a 11.35 þ 0.83**a 7.42 þ 1.04a 2.25 þ 0.10a
Immunised-
challenged
3^5 68.41 þ 1.01**a;b;c 33.56 þ 1.02**a;c 68.32 þ 0.98**b;c 4.69 þ 0.79*a;**b 1.22 þ 0.36 0.59 þ 0.09b
9^11 68.73 þ 1.08**a;b 38.29 þ 0.98*a;**b 49.64 þ 0.99**a;b;c 9.64 þ 0.13**a;b;c 2.81 þ 0.22a;b 1.18 þ 0.06a
17^21 72.10 þ 0.90*a;*b 52.38 þ 0.98**a;b;
*c
33.36 þ 0.94**a;b;c 13.68 þ 0.99**a;b;
*c
8.19 þ 0.06a;b 2.60 þ 0.03a;b
*P6 0.05; **P6 0.01 as compared to control (a); infected (b); immunised (c); immunised-challenged. All values are expressed as mean þ S.D.
CD4+, helper/inducer T cells ; CD8+, suppressor/cytotoxic T cells ; p.i., post infection; PI, post immunisation; PI/PC, post immunisation/post
challenge.
Fig. 3. Trophozoite load in the small intestine during the course of G. lamblia infection. hatched bars: infected group; cross-hatched bars,
immunised-challenged group. Results are expressed as mean þ S.D. 3^5 days, establishment phase; 9^11 days, acute phase; 17^21 days, de-
cline phase. **P6 0.01.
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The separation of PP and splenic lymphocytes also
provided a pure population of viable (s 90%) cells
as assessed by 0.2% trypan blue exclusion. The cell
count was 5.6 þ 0.86U107 sp per animal and
9.3 þ 0.34U106 pp per animal). The di¡erential re-
sponses of IEL and LPL observed during the colo-
nisation, peak and decline phases of giardial infec-
tion were considered speci¢c to G. lamblia infection
since the observed alterations occurred following the
inoculation of trophozoites. No alterations in the
FEMSIM 960 8-2-99
Table 3
Percentage of T cell subsets and immunoglobulin-containing cells in Peyer’s patches (PP)
Group Days Total T CD4+ CD8+ IgG IgA IgM
(p.i. ;PI;
PI/PC)
(a) Control 3^5 28.17 þ 0.84 17.44 þ 0.75 6.20 þ 0.54 29.03 þ 0.95 4.52 þ 0.26 25.55 þ 0.87
9^11 29.21 þ 0.86 17.99 þ 0.80 6.88 þ 0.57 29.98 þ 0.92 4.93 þ 0.70 26.39 þ 0.81
17^21 28.31 þ 0.85 17.53 þ 1.01 6.19 þ 0.63 29.79 þ 0.91 4.52 þ 0.26 25.55 þ 0.87
(b) Infected 3^5 47.92 þ 0.94**a 30.72 þ 0.70**a 6.42 þ 0.79 29.88 þ 0.54 10.27 þ 0.66**a 33.64 þ 5.43**a
9^11 38.97 þ 0.93**a 17.74 þ 0.94 6.82 þ 0.69 29.25 þ 0.65 16.66 þ 0.94**a 47.60 þ 0.40**a
17^21 29.06 þ 0.92 17.53 þ 1.01 6.36 þ 0.84 29.28 þ 1.15 30.67 þ 0.97**a 32.18 þ 0.60**a
(c) Immunised 3^5 10.35 þ 0.85**a 9.07 þ 0.88**a 20.00 þ 0.93**a 28.01 þ 0.99 13.49 þ 1.17**a 12.34 þ 0.88**a
9^11 19.44 þ 0.88**a 17.39 þ 0.92 9.36 þ 0.89**a 53.73 þ 0.89**a 3.76 þ 0.85 40.35 þ 0.87**a
17^21 18.22 þ 0.62**a 12.07 þ 0.88 4.45 þ 0.95 81.65 þ 0.97**a 3.62 þ 0.89 48.30 þ 0.72**a
Immunised-
challenged
3^5 16.16 þ 0.97**a;b;c 10.55 þ 0.80**
a;b;*c
21.85 þ 0.95**
a;*c
39.08 þ 0.69**
a;*b
16.53 þ 0.06**a;b;c 19.19 þ 0.99*
a;c;**b
9^11 23.18 þ 0.91**a;b;c 17.76 þ 0.88 10.47 þ 0.93**a;b 58.38 þ 1.00**
a;c;*b
4.37 þ 0.10**b 44.62 þ 0.70**a;b;c
17^21 21.62 þ 0.92**a;b;c 9.46 þ 0.94**a;b;c 5.16 þ 0.96 83.33 þ 0.90**a;b 10.77 þ 0.97**a;b 54.39 þ 0.99**a;b;c
*P6 0.05; **P6 0.01 as compared to control (a); infected (b); immunised (c); immunised-challenged. All values are expressed as mean þ S.D.
CD4+, helper/inducer T cells ; CD8+, suppressor/cytotoxic T cells ; p.i., post infection; PI, post immunisation; PI/PC, post immunisation/post
challenge.
Table 2
Percentage of T cell subsets and immunoglobulin-containing cells in lamina propria (LPL)
Group Days Total T CD4+ CD8+ IgG IgA IgM
(p.i. ;PI;
PI/PC)
(a) Control 3^5 38.63 þ 0.91 25.42 þ 0.90 16.76 þ 0.93 22.19 þ 1.02 17.83 þ 0.88 3.08 þ 0.20
9^11 39.59 þ 0.89 26.51 þ 0.79 17.81 þ 0.10 23.40 þ 1.05 16.90 þ 0.98 3.02 þ 0.15
17^21 38.78 þ 0.98 24.91 þ 0.54 15.90 þ 0.88 21.35 þ 1.03 18.79 þ 0.77 3.05 þ 0.23
(b) Infected 3^5 60.33 þ 1.11**a 26.51 þ 0.53 23.40 þ 1.04**a 21.07 þ 0.93 17.76 þ 0.98 8.25 þ 0.36**a
9^11 68.65 þ 0.85**a 25.49 þ 0.88 28.88 þ 1.03**a 23.48 þ 0.78 18.76 þ 0.35 3.53 þ 0.32*a
17^21 56.50 þ 0.88**a 33.83 þ 0.94**a 16.10 þ 0.20 32.94 þ 0.86**a 33.06 þ 0.54**a 2.16 þ 0.68**a
(c) Immunised 3^5 80.64 þ 0.86**a 33.90 þ 5.32*a 43.65 þ 1.18**a 7.46 þ 0.56**a 4.54 þ 0.23**a 3.08 þ 0.28
9^11 59.34 þ 0.69**a 25.84 þ 0.82 18.83 þ 0.82 10.76 þ 0.86**a 11.00 þ 0.89**a 3.03 þ 0.07
17^21 4.97 þ 0.65**a 2.89 þ 0.89**a 1.31 þ 0.09**a 58.57 þ 1.14**a 50.33 þ 0.98**a 3.06 þ 0.21
Immunised-
challenged
3^5 86.38 þ 0.02**a;b;c 37.26 þ 0.94**a;b 43.99 þ 1.26**a;b 7.96 þ 0.60**a;b 4.73 þ 0.70**a;b 3.09 þ 0.22
9^11 60.22 þ 0.90**a 25.84 þ 0.84 16.73 þ 0.90**b 17.89 þ 0.84**
a;b;c
15.30 þ 0.03**
a;b;c
3.06 þ 0.10**b
17^21 18.36 þ 0.89**a;b;c 2.97 þ 0.80**a;b 1.48 þ 0.41**a;b 53.34 þ 0.70**
a;b;*c
52.55 þ 0.48**
a;b;*c
3.08 þ 0.25
*P6 0.05; **P6 0.01 as compared to control (a); infected (b); immunised (c); immunised-challenged. All values are expressed as mean þ S.D.
CD4+, helper/inducer T cells ; CD8+, suppressor/cytotoxic T cells ; p.i., post infection; PI, post immunisation; PI/PC, post immunisation/post
challenge.
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lymphocyte T cell subsets or antibody-producing
cells were noticed in uninfected control animals
kept under identical conditions.
The establishment and acute phases of G. lamblia
infection in the infected animals in the present study
accompanied a signi¢cant in£ux of Lyt 2 (suppres-
sor/cytotoxic lymphocytes) (Tables 1 and 2) and a
signi¢cant decline in IgA-bearing plasma cells (Ta-
bles 1 and 2) in the gut (IEL/LPL). It has earlier
been shown that the intestinal lymphocytes isolated
during the course of giardial infection from NMRI
mice were incapable of killing the G. lamblia troph-
ozoites in vitro either in the presence or in the ab-
sence of G. lamblia-speci¢c antibodies. Thus the Lyt
2 cells in£uxed as a result of Giardia infection ap-
peared not to be cytotoxic T cells in nature but were
suppressor T cells [33]. This in£ux of suppressor T
cells during establishment and peak phases of giar-
dial infection has been suggested by these authors to
be due to the feedback suppressor pathway which
might have been triggered very early or preferentially
after the immune induction following G. lamblia in-
fection due to the release of some ES products by the
multiplying trophozoites. An early selective localisa-
tion of suppressor T cells observed in the infected
animals may therefore explain the signi¢cantly low
level of IgA-bearing cells in the IEL and LPL of
these animals as well as in the lamina propria of
immunised animals during establishment and peak
phases of giardial infection. The fact that ES prod-
ucts signal the generation and localisation of Lyt 2
cells in the gut accounts for a signi¢cant induction of
CD8+ T cells in the PP of immunised animals (Table
3), which is the main site of antigen presentation.
The present study, however, indicates a signi¢cant
increase in the percentage of IgA-bearing cells in
the PP of immunised as well as immunised-chal-
lenged animals (Table 3), which might have been
responsible for the inhibition of G. lamblia tropho-
zoites to be colonised in the intestine.
Further, it was observed that the decline phase of
G. lamblia infection in the infected as well as the
immunised and immunised-challenged animals in-
volved a selective induction of CD4+ T cells in the
IEL (Table 1) and LPL (Table 2) along with a sig-
ni¢cant reduction of CD8+ T cells (Tables 1 and 2).
This phase of infection was also found to be accom-
panied by an increased number of IgA- and IgG-
bearing cells (Tables 1 and 2 respectively). It thus
appears that the inducer T cells may be responsible
for the induction of antibody-dependent e¡ector re-
sponses. It has earlier been noticed that s-IgA bound
to the surface of Giardia trophozoites results in the
clearance of the same from the gut of infected ani-
mals [34,35] while parasites with negligible surface-
bound s-IgA persisted during the decline phase of
infection [36,37]. The anti-giardial IgA responses
have also been noticed to be altered in mice depleted
of T helper lymphocytes [35]. Indeed it has earlier
been observed that the clearance of G. muris infec-
tion in mice is regulated by induction of CD4+
T cells [35]. Based on the ¢ndings of others and
ourselves, we feel that a signi¢cant enhancement of
T helper/inducer activity along with a signi¢cant en-
hancement of IgA-bearing cells results in the clear-
ance of the trophozoites from the intestine. At the
same time, the role of IgG in the clearance of Giardia
cannot be ignored, since a signi¢cant increase in the
IgG-bearing cells during the decline phase of the ex-
perimental animals was observed, although surface-
bound parasite-speci¢c IgG antibodies on the troph-
ozoites of Giardia isolated from the gut lumen of
mice reported by Heyworth et al. [38] suggested a
possible role of IgG in the modulation of the infec-
tion at gut level. However, the involvement of locally
synthesised IgG in providing long-lasting protection
against G. lamblia requires further investigation.
In contrast, the establishment phase of G. lamblia
infection in the IEL, LPL as well as PP of the in-
fected mice was accompanied by proliferation of
IgM-bearing cells (Tables 1 and 2 respectively) sug-
gesting that during the early stage of G. lamblia in-
fection the immunoglobulin production was predom-
inantly of the IgM isotype. This observation agrees
well with the earlier reports in human giardiasis [39^
41]. The proliferation of IgM-bearing cells during the
acute phase of the disease is not a¡ected by the feed-
back suppressor pathway as the initial di¡erentiation
of pre-B cells to immune IgM-bearing cells is inde-
pendent of T cells or lymphokines [42].
The present data demonstrate that the prior im-
munisation of mice with ESP resulted in a signi¢cant
stimulation of local immunity as evidenced by a sig-
ni¢cant increase in IgA- and IgG-bearing cells in the
LPL-immunised animals (Table 2) which probably
prevented the establishment of G. lamblia tropho-
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zoites in the immunised-challenged animals. Further,
it was observed that the IgM-bearing cells in the
LPL of the immunised animals (Table 2) and control
animals were statistically identical. These ¢ndings
point to the fact that the genetic switching of IgM-
bearing cells to those recognising the antigen
through receptors of the IgG and IgA classes has
been completed during the immunisation schedule
and memory IgG and IgA clones which were formed
gave a booster response upon challenge in immu-
nised animals.
A signi¢cant decline in the percentage of total T
cells was observed within the PP of the immunised
and immunised-challenged animals during 3^5 days
PI/PC (Table 3). It appears that most of the acti-
vated T cells including CD4+ T cells might have
migrated to the distal mucosal e¡ector sites, such
as the lamina propria, as the percentage of these cells
was found to be signi¢cantly increased in the LPL
and IEL of these animals (Tables 2 and 1 respec-
tively) where further stimulation and terminal di¡er-
entiation into antibody-producing cells takes place
[43^45]. Less is known about the induction and traf-
¢cking of primed T cells after oral immunisation,
particularly in man. However, immunisation of PP
with keyhole limpet haemocyanin in an animal mod-
el induced a population of primed T cells which sug-
gested within the circulation before homing speci¢-
cally to the gut [46]. In the gut, immunisation by the
oral or enteral route has been found to e¡ectively
stimulate a speci¢c mucosal immune response
[20,47]. The immunogen probably makes contact
with immunocompetent B and T cells in the PP,
and these cells, while di¡erentiating, then migrate
to the mesenteric lymph nodes and further via the
thoracic duct, enter into the systemic circulation.
Committed, migrating cells eventually return to the
intestinal mucosa where further stimulation and ter-
minal di¡erentiation into antibody-producing cells
takes place [43,48]. On repeated immunisation, the
immunogen may also, to a lesser extent, directly
stimulate antigen-speci¢c memory cells in gut lamina
propria [49,50]. It remains poorly de¢ned whether
the IgA class predominance of the gut mucosal re-
sponse is already initiated in the PP or results from
later in£uences on the B cells, i.e., while en route to
or during this ¢nal di¡erentiation in the lamina
propria [51,52].
In the spleen (Table 4) of immunised animals, we
found a signi¢cant increase in the percentage of
CD4+ T cells. An increase in CD4+ T cells appears
to be bene¢cial as it related very well with elimina-
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Table 4
Percentage of T cell subsets and immunoglobulin-containing cells in spleen (SP)
Group Days Total T CD4+ CD8+ IgG IgA IgM
(p.i. ;PI;
PI/PC)
(a) Control 3^5 56.15 þ 0.90 25.10 þ 0.99 27.26 þ 0.96 52.68 þ 0.98 8.22 þ 0.34 32.71 þ 0.92
9^11 57.17 þ 0.92 24.23 þ 0.81 28.31 þ 0.91 53.70 þ 0.91 8.99 þ 0.40 33.56 þ 0.90
17^21 58.14 þ 0.91 24.40 þ 0.87 26.46 þ 0.94 52.93 þ 0.94 9.03 þ 0.63 34.69 þ 0.91
(b) Infected 3^5 26.38 þ 0.98**a 25.21 þ 0.91 6.49 þ 0.54**a 53.29 þ 0.98 1.96 þ 0.34**a 33.06 þ 0.93
9^11 24.32 þ 0.92**a 7.69 þ 0.91**a 3.33 þ 0.07**a 35.53 þ 0.95**a 11.39 þ 0.89**a 13.74 þ 0.96**a
17^21 50.28 þ 0.92**a 27.29 þ 0.92*a 11.49 þ 1.01**a 58.40 þ 0.90**a 2.63 þ 0.13**a 48.25 þ 0.95**a
(c) Immunised 3^5 43.56 þ 0.94**a 31.43 þ 0.91**a 5.64 þ 0.95**a 49.37 þ 1.01**a 0.89 þ 0.16**a 50.50 þ 0.90**a
9^11 39.31 þ 0.91**a;b;c 27.27 þ 0.28 4.21 þ 0.28**a 58.24 þ 0.94**a 0.31 þ 0.05**a 34.05 þ 0.93
17^21 32.94 þ 0.96**a 24.96 þ 0.94 8.60 þ 1.46**a 62.67 þ 0.97**a 0.83 þ 0.13**a 34.33 þ 0.93
Immunised-
challenged
3^5 55.84 þ 0.95**b;c 23.12 þ 0.94**c 11.18 þ 0.98**
a;b;c
55.39 þ 0.99*a;**
c
1.69 þ 0.43**a;c 39.53 þ 0.98**a;c
9^11 50.91 þ 0.98**a;b;c 28.76 þ 0.96**a;b 9.98 þ 0.97**
a;b;c
22.90 þ 0.99**a;b;c 0.63 þ 0.35**a;b 13.05 þ 0.90**a;c
17^21 54.61 þ 0.99**b;c 32.69 þ 0.99**
a;b;c
13.82 þ 0.96**a;c 2.48 þ 0.02**a;b;c 0.20 þ 0.10**a;b;c 5.66 þ 0.96**a;b;c
*P6 0.05; **P6 0.01 as compared to control (a); infected (b); immunised (c); immunised-challenged. All values are expressed as mean þ S.D.
CD4+, helper/inducer T cells ; CD8+, suppressor/cytotoxic T cells ; p.i., post infection; PI, post immunisation; PI/PC, post immunisation/post
challenge.
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tion of G. lamblia infection where it has been seen
that when the local immunologic response is at its
peak, G. lamblia is eliminated from the gut. We also
found a sharp decline in IgA-bearing cells on the one
hand and a signi¢cant increase in IgM-bearing cells
on the other, in the spleen of the immunised animals
during the establishment phase of the infection. It is
quite likely from these ¢ndings that IgM may have
taken over the functions of IgA resulting in the clear-
ance of G. lamblia trophozoites. An experimental
study of giardiasis utilising anti-IgM-treated mice
also indicated the importance of IgM in regulation
of giardial infection [14]. Farthing [53] has also re-
ported that anti-giardial IgM potentiates the lytic
e¡ects of complement on G. lamblia. The role of
Giardia-speci¢c IgM response in regulating the dis-
ease process especially in immunocompromised hosts
has also been elucidated [54].
However, in-depth investigations are required es-
pecially in view of the fact that the parasite remains
con¢ned to the intestinal lumen without invading the
intestinal mucosa. It may thereby fail to elicit either
a systemic in£ammatory response or alterations in
lymphocyte subsets in the peripheral blood [55].
The small bowel morphological changes observed
during G. lamblia infection are believed to be deter-
mined, at least in part, by T cell-dependent activity
[13]. Indeed, it is the gut-associated lymphoid tissue
that plays a prominent role in the host defense
against intestinal pathogens. The cells express mainly
the CD4 antigen in the lamina propria whereas T
cells expressing the CD8 antigen and NK cells com-
prise the majority of the IEL [56,57]. It remains to be
determined to what degree the local intestinal im-
mune response and changes in intestinal lymphocyte
subsets are correlated by those detected in the pe-
ripheral blood [55]. Further studies are therefore
needed to elucidate the changes in intestinal mucosal
lymphocyte subsets occurring during G. lamblia in-
fection and to correlate them with lymphocyte subset
distribution in the circulation.
The present study further revealed a signi¢cant
increase in the population of total T as well as
CD4+ T cells in the PP of infected animals (Table
3) during the establishment phase of infection. Ear-
lier reports on PP ‘switch’ T cells which possess the
surface antigens and the known regulatory functions
of T cells led to the hypothesis that an increase in the
number of relative percentage of PP CD4+ T cells
initiates subsequent events in the intestinal immune
response [58]. The relative de¢ciency of these cells, as
compared to CD8+ T cells in immunode¢cient nude
mice, provided indirect support for this hypothesis
[59].
The cellular events within PP that follow antigen
presentation are not well understood. ‘Switch’ T
cells, which are T helper cells, have been isolated
from PP and in vitro have been demonstrated to
participate in the immunoglobulin isotype switching
that occurs with maturation of B cells into functional
plasma cells [60]. In vitro cloned PP ‘switch’ T cells
proliferate when exposed to autologous B cells, T
cells and macrophages, suggesting that cell-cell inter-
actions are important in the generation of these
‘switch’ T cells [61].
Thus, from the present study, it appears that IgA
antibodies act as a ¢rst line of defense for immune
exclusion of the parasite at the mucosal surface, i.e.,
blocking the colonisation of mucosal surface by the
parasite. On the other hand, the presence of circulat-
ing anti-giardial antibodies [62^64] in clinical giar-
diasis patients and speci¢c serum IgG and IgA anti-
bodies in experimental giardiasis [65] in mice
indicates stimulation of the host humoral immune
system. The demonstration of anti-ESP antibodies
observed in the serum of immunised animals (Fig.
4) in the present study indicates that the antigen
must cross the intestinal mucosa to stimulate the
systemic lymphoid tissue. These antibodies may
also be due to transepithelial translocation of immu-
noglobulins from the intestinal lumen produced by
local (mucosal) antibody-producing cells stimulated
by the parasite antigen [66].
The development of in vitro culture techniques for
Giardia a decade ago has secured an adequate supply
of antigen such that serum antibody responses to
Giardia are beginning to be well characterised,
most commonly by ELISA. Experimental infections
in mice con¢rm the appearance of speci¢c anti-Giar-
dia IgA and IgG in intestinal secretions and clear-
ance of the parasite relates closely to rising concen-
trations of these antibodies in the intestinal £uid.
Although circulating anti-giardial antibodies have
been demonstrated in individuals su¡ering from giar-
diasis [61,64], their precise biological role has re-
mained unclear. Vinayak et al. [33] have demon-
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strated that a speci¢c antibody response to plasma
membrane (PM) and surface antigen GLSA 56 oc-
curs in giardiasis. Comparison of groups of patients
revealed low levels of antibodies against PM and
GLSA 56 in persistent giardiasis, compared with
non-persistent and asymptomatic cases.
In the present study, the levels of IgA, IgM as well
as IgG were signi¢cantly increased in the immunised
as well as immunised-challenged animals as com-
pared to those of unimmunised control animals
(Fig. 4). We observed maximum levels of IgM in
the serum of the immunised as well as immunised-
challenged animals (Fig. 4) which was found to be
signi¢cantly higher compared to those of IgA and
IgG serum levels (Fig. 4A,B respectively) at both
3^5 and 9^11 days PI/PC. But subsequently, the lev-
els of IgG in the serum increased signi¢cantly as
compared to those of IgM and IgA levels at 17^21
days PI/PC. It has been reported that anti-giardial
IgM is produced earlier in infection, but antibody
titres decrease rapidly within 2^3 weeks after the
onset of infection [67]. An experimental study of
giardiasis utilising anti-IgM-treated mice has also in-
dicated the importance of IgM in regulation of giar-
dial infection [14]. We further observed that unim-
munised (control) animals had negligible levels of
anti-ESP antibodies (Fig. 4). It may, therefore, sug-
gest that the attainment of a signi¢cant level of anti-
ESP antibodies resulted in the complete elimination
of the parasite. In other words, the clearance of G.
lamblia infection correlated well with the develop-
ment of anti-ESP antibodies. Therefore, the possibil-
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Fig. 4. Humoral immune response (levels of anti-ESP antibodies in serum). A: Serum IgA. B: Serum IgM. C: Serum IgG. Bars indicate
3^5, 9^11 and 17^21 days post infection (p.i.), post immunisation/post challenge (PI/PC). *P6 0.05; **P6 0.01 as compared to control
(a); infected (b); immunised (c) ; immunised-challenged. Results are expressed as mean þ S.D. of three separate experiments.
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ity exists that the ES antigen from the live tropho-
zoites was absorbed across the intestinal mucosa.
Alternatively there may have been an interaction of
viable trophozoites with the surface epithelium re-
sulting in activation and uptake by tissue macro-
phages. In support of this hypothesis is the work
by Owen et al. [68], who demonstrated phagocytosis
of G. muris by macrophages present in mouse PP.
The immunisation of animals with ES antigen re-
sulted in a signi¢cant titre of anti-ESP antibodies
indicating that this protein is highly immunogenic
and it seems that ESP is one of the major antigens
of G. lamblia responsible for protection against the
disease.
It is therefore pertinent to conclude that ESP of
the parasite can be considered a candidate for immu-
noprophylactic studies. Such an agent may have a
useful role in protecting vulnerable populations like
children or persons from non-endemic areas travel-
ling to endemic areas. Detailed investigations are es-
sential to study the mechanisms by which the para-
site evades the e¡ector immune mechanisms.
Nevertheless, the investigations quoted above clearly
indicate that although gut-associated immune mech-
anisms are involved in regulating giardial infection,
other e¡ector immune mechanisms like mucosal
mast cells, macrophages and other non-speci¢c intes-
tinal factors cannot be ignored.
References
[1] Hartong, W.A., Gourley, W.K. and Arvanitakis, C. (1979)
Giardiasis in clinical spectrum and functional structural ab-
normalities of small intestine mucosa. Gastroenterology 77,
61^69.
[2] Char, S., Shetty, N., Narasimha, M., Elliott, E., Macaden, R.
and Farthing, M.J.G. (1991) Serum antibody response in chil-
dren with Giardia lamblia infection and identi¢cation of an
immunodominant 57 kDa antigen. Parasite Immunol. 13,
329^337.
[3] Clark, J.T. and Holberton, D.V. (1986) Plasma membrane
isolated from Giardia lamblia : identi¢cation of membrane pro-
teins. Eur. J. Cell. Biol. 42, 200^206.
[4] Crossley, R. and Holberton, D.V. (1983) Characterisation of
proteins from the cytoskeleton of Giardia lamblia. J. Cell. Sci.
59, 81^103.
[5] Edson, C.M., Farthing, M.J.G., Thorley-Lawson, D.A. and
Keusch, G.T. (1986) An 88000 MW Giardia lamblia surface
protein which is immunogenic in humans. Infect. Immun. 54,
621^665.
[6] Heyworth, M.F. (1990) Biological signi¢cance of Giardia spe-
ci¢c antibodies. West. J. Med. 152, 293^295.
[7] Heyworth, M.F. and Vergara, J.A. (1994) Giardia muris
trophozoite antigenic targets for mouse intestinal IgA anti-
body. J. Infect. Dis. 169, 395^398.
[8] Kum, K., Khanna, R., Mehta, S., Khuller, M. and Vinayak,
V.K. (1987) Plasma membrane associated antigen of tropho-
zoites of axenic G. lamblia. Trans. R. Soc. Trop. Med. Hyg.
82, 439^444.
[9] Rosof, J.D. and Stibbs, H.H. (1986) Isolation and identi¢ca-
tion of a Giardia lamblia-speci¢c stool antigen (GSA 65) useful
in coprodiagnosis of giardiasis. J. Clin. Microbiol. 23, 905^
910.
[10] Vinayak, V.K., Dutt, P. and Puri, M. (1991) An immunoen-
zymatic dot-ELISA for the detection of Giardia lamblia anti-
gen in stool eluates of clinical cases of giardiasis. J. Immunol.
Methods 137, 245^251.
[11] Vinayak, V.K., Kum, K., Chandna, R., Venkateshwarlu, K.
and Mehta, S. (1985) Detection of Giardia lamblia antigens in
the faeces by counterimmunoelectrophoresis. Pediat. Infect.
Dis. J. 4, 383.
[12] Ament, M.E. and Rubin, C.E. (1972) Relation of giardiasis to
abnormal intestinal structure and function in gastrointestinal
immunode¢ciency syndromes. Gastroenterology 62, 216^226.
[13] Roberts-Thomson, I.C. and Mitchell, G.F. (1978) Giardiasis
in mice. I. Prolonged infections in certain mouse strains and
hypothymic (nude) mice. Gastroenterology 75, 57^61.
[14] Snider, D.P., Gordon, J., McDermott, M.R. and Undertown,
B.J. (1985) Chronic Giardia muris infection in anti-IgM
treated mice. Analysis of immunoglobulin and parasite speci¢c
antibody in normal and immunoglobulin de¢cient animals.
J. Immunol. 134, 4153^4162.
[15] Stevens, D.P., Frank, D.M. and Mahmoud, A.A.F. (1978)
Thymus dependency of host resistance to Giardia muris infec-
tion: Studies in nude mice. J. Immunol. 120, 680^682.
[16] Holberton, D.V. and Ward, A.P. (1981) Isolation of the cy-
toskeleton from Giardia. Tubulin and a low molecular weight
protein associated with microribbon structures. J. Cell. Sci. 47,
139^166.
[17] Scott, M.J. and Snary, D. (1979) Protective immunisation of
mice using cell surface glycoprotein from Trypanosoma cruzi.
Nature 282, 73^74.
[18] Aggarwal, A., Sharma, G.L., Bhatia, A., Naik, S.R., Chakra-
varti, R.N. and Vinayak, V.K. (1980) E¡ects of corticosteroid
and irradiation on experimental G. lamblia infection in mice.
Ann. Trop. Med. Parasitol. 74, 361^371.
[19] Ouchterlony, O. (1962) Di¡usion in gel methods for immuno-
logical analysis II. In: Progress in Allergy (Kallos and Waks-
man, B.H., Eds.), Vol. VI, pp. 30^154. Basel, Karger.
[20] Lange, S. and Holmgren, J. (1978) Protective antitoxic cholera
immunisation in mice: in£uence of route and number of im-
munisations and mode of action of protective antibodies. Acta
Pathol. Microbiol. Scand. C Immunol. 86, 145^152.
[21] Vasudeva, V., Ganguly, N.K., Anand, B.S., Radhakrishnan,
V.D. and Mahajan, R.C. (1982) A study of Giardia infection
in irradiated and thymectomised mice. J. Trop. Med. Hyg. 85,
119^122.
FEMSIM 960 8-2-99
H. Kaur et al. / FEMS Immunology and Medical Microbiology 23 (1999) 93^105 103
[22] Davies, M.D.J. and Parrott, D.M.V. (1981) Preparation and
puri¢cation of lymphocytes from the epithelium and lamina
propria of murine small intestine. Gut 22, 481^488.
[23] Tagliabue, A., Befus, A.D., Clark, D.A. and Bienenstock, J.
(1982) Characteristics of natural killer cells in the murine in-
testinal epithelium and lamina propria. J. Exp. Med. 155,
1785^1796.
[24] Lycke, N., Lindholm, L. and Holmgren, J. (1983) IgA isotype
restriction in the mucosal but not in the extramucosal immune
response after oral immunisations with cholera toxin or chol-
era B subunit. Int. Arch. Allergy Appl. Immunol. 72, 119^
127.
[25] Jondal, M., Holm, G. and Wigzell, H. (1972) Surface markers
on human lymphocytes. J. Exp. Med. 136, 207^215.
[26] Hornquist, E., Goldschmidt, J., Holmdahl, R. and Lycke, N.
(1991) Host defense against cholera toxin is strongly CD4+ T
cell dependent. Infect. Immun. 59, 3630^3638.
[27] Voller, A., Bidwell, D. and Bartlett, A. (1976) Enzyme immu-
noassay in diagnostic medicine. Theory and Practice. Bull.
WHO, 53^55.
[28] Newcomb, R.W., Ischizaka, K. and Denald, B.L. (1969) Hu-
man IgG and IgA diphtheria antitoxins in serum, nasal £uids
and saliva. J. Immunol. 103, 215^219.
[29] Ogra, P. (1971). The secretory immunoglobulin system of the
gastrointestinal tract. In: The Secretory Immunological Sys-
tem (Dayton, D.H. Jr., Small, P.A. Jr., Chanock, R.M. and
Tomasi, T.B. Jr., Eds.), p. 259. US Government Printing Of-
¢ce, Washington, DC.
[30] Pierce, N.F. and Gowans, J. (1975) Cellular kinetics of the
intestinal immune response to cholera toxoid in rats. J. Exp.
Med. 142, 1550^1563.
[31] Dolezel, J. and Bienenstock, J. (1971) Gamma A and non
gamma A immune response after oral and parenteral immu-
nisation of hamster. Cell. Immunol. 2, 458^469.
[32] Ferguson, A., McClure, S.P. and Townley, R.R.W. (1976)
Epithelial lymphocytes in¢ltration in biopsies from children
with diarrhoea. Acta Pediatr. Scand. 65, 541^546.
[33] Vinayak, V.K., Kum, K. and Khanna, R. (1989) Serum anti-
bodies to giardial surface antigens: lower titres in persistent
than in non-persistent giardiasis. J. Med. Microbiol. 30, 207^
212.
[34] Heyworth, M.F. (1989) Intestinal IgA response to Giardia
muris depleted of helper T lymphocytes in immunocompetent
mice. J. Parasitol. 75, 246^251.
[35] Waight Sharma, A. and Mayrhofer, G. (1988) Biliary anti-
body responses in rats infected with rodent Giardia duodenalis
isolates. Parasite Immunol. 10, 181^191.
[36] Khanna, R., Joshi, K., Kum, K., Malik, A.K. and Vinayak,
V.K. (1990) An ultrastructural analysis of changes in surface
architecture of intestinal mucosa following Giardia lamblia
infection in mice. Gastroenterol. Japon. 25, 649^658.
[37] Vinayak, V.K., Khanna, R. and Kum, K. (1990) Gut associ-
ated immune responses in clinical and experimental giardiasis :
an overview. Trop. Gastroenterol. 11, 4^8.
[38] Heyworth, M.F., Kung, J.E. and Eriksson, E.C. (1986) Clear-
ance of Giardia muris infection in mice de¢cient in natural
killer cells. Infect. Immun. 54, 903^904.
[39] Goka, A.K.J., Rolston, D.D.K., Mathan, V.I. and Farthing,
M.J.G. (1987) Human serum IgA response to Giardia lamblia.
Gut 28, A1351.
[40] Ridley, M.J. and Ridley, D.S. (1976) Serum antibodies and
jejunal histology in giardiasis associated with malabsorption.
J. Clin. Pathol. 29, 30^34.
[41] Thompson, A., Rowland, R. and Hecker, R. (1977) Immuno-
globulin bearing cells in giardiasis. J. Clin. Pathol. 30, 292^
294.
[42] Abney, E.R., Cooper, M.D., Kearney, J.F., Lawton, A.R. and
Parkhouse, R.M.E. (1978) Sequential expression of immuno-
globulin in developing mouse B lymphocytes: a systemic sur-
vey that suggests a model for the generation of immuno-
globulin class diversity. J. Immunol. 120, 2041^2049.
[43] Biewenga, J., VanRees, E.P. and Sminia, T. (1993) Induction
and regulation of IgA responses in microenvironment of gut.
Clin. Immunol. Immunopathol. 67, 1^7.
[44] Czerkinsky, C., Svennerholm, A.M. and Holmgren, J.F.
(1993) Induction and assessment of immunity at extramucosal
surfaces in humans: Implications for vaccine development.
Clin. Infect. Dis. 16, 106^116.
[45] Miller, C.J., McGhee, J.R. and Gardner, M.B. (1992) Biology
of disease, mucosal immunity, HIV transmission and AIDS.
Lab. Invest. 68, 129^145.
[46] Dunkley, M.L. and Husband, A.J. (1986) The induction and
migration of antigen-speci¢c helper cells for IgA responses in
the intestine. Immunology 15, 379^385.
[47] Crabbe, P.A., Nash, D.R., Bazin, H., Eyssen, H. and Here-
mans, J.F. (1967) Antibodies of the IgA type in intestinal
plasma cells of germfree mice after oral or parenteral immu-
nisation with ferritin. J. Exp. Med. 130, 723^744.
[48] Husband, A.J. and Gowans, J.L. (1978) The origin and anti-
gen dependent distribution of IgA containing cells in the in-
testine. J. Exp. Med. 148, 1146^1160.
[49] Husband, A.J. (1982) Kinetics of extravasation and redistrib-
ution of IgA-speci¢c antibody containing cells in the intestine.
J. Immunol. 128, 1355^1359.
[50] Pierce, N.F. and Cray, W.C. (1982) Determinants of the local-
isation, magnitude and duration of a speci¢c IgA plasma cell
response in enterically immunised rats. J. Immunol. 128,
1311^1315.
[51] Elson, C.O., Heck, J.A. and Strober, W. (1979) T cell regu-
lation of murine IgA synthesis. J. Exp. Med. 149, 632^643.
[52] Tseng, J. (1981) IgA allotype suppression in mice: a cellular
implication for the IgA preponderance in the gut. Cell. Im-
munol. 65, 247^257.
[53] Farthing, M.J.G. (1993) Diarrhoeal disease: Current concepts
and future challenges: Pathogenesis of giardiasis. Trans. Soc.
Trop. Med. Hyg. 87, Suppl. 3, 17^21.
[54] Khanna, R., Kum, K. and Vinayak, V.K. (1990) Gut-associ-
ated immune e¡ector responses in immunocompetent and im-
munocompromised mice with Giardia lamblia. FEMS Micro-
biol. Immunol. 2, 137^145.
[55] Schlesinger, M., Granot, E., Rabinowitz, R. and Deckelbaum,
R.J. (1993) Peripheral blood lymphocyte subsets in infants
with diarrhoea with and without Giardia lamblia infection.
Pediatr. Res. 33, 15^18.
FEMSIM 960 8-2-99
H. Kaur et al. / FEMS Immunology and Medical Microbiology 23 (1999) 93^105104
[56] Kelly, J., O’Farrelly, C., O’Mahoney, C., Weir, D.G. and
Feighery, C. (1987) Immunoperoxidase demonstration of the
cellular composition of the normal and coeliac small bowel.
Clin. Exp. Immunol. 68, 177^188.
[57] Selby, W.S., Janossy, G., Bo¢ll, M. and Jewell, D.P. (1983)
Lymphocyte subpopulations in the human small intestine. The
¢ndings in normal mucosa and in the mucosa of patients with
adult coeliac disease. Clin. Exp. Immunol. 52, 219^228.
[58] Strober, W. (1982) The regulation of mucosal immune system.
J. Allergy Clin. Immunol. 70, 225^230.
[59] Carlson, J.R., Heyworth, M.F. and Owen, R.L. (1985) Re-
sponse of Peyer’s patch T cell subpopulation to Giardia muris
infection (abstr.) Clin. Res. 33, 32A.
[60] Kawanishi, H., Saltzman, L.E. and Strober, W. (1983) Mech-
anisms regulating IgA class speci¢c immunoglobulin produc-
tion in murine gut associated lymphoid tissues. I. T cells de-
rived from Peyer’s patches that switch sIgM B cells to sIgA B
cells in vitro. J. Exp. Med. 157, 433^450.
[61] Kawanishi, H., Ozato, K. and Strober, W. (1985) The prolif-
erative response of cloned Peyer’s patch switch T cells to syn-
geneic and allogeneic stimuli. J. Immunol. 134, 3586^3591.
[62] Smith, P.D., Gillin, F.D., Brown, W.R. and Nash, T.E. (1981)
IgG antibody to Giardia lamblia detected by enzyme linked
immunosorbent assay. Gastroenterology 80, 1476^1480.
[63] Smith, P.D., Gillin, F.D., Spira, W.M. and Nash, T.E. (1982)
Chronic giardiasis : Studies on drug sensitivity, toxin produc-
tion and host immune response. Gastroenterology 83, 797^
803.
[64] Vinayak, V.K., Jain, P. and Naik, S.R. (1978) Demonstration
of antibodies in Giardiasis using immunodi¡usion technique
with Giardia cysts as antigen. Ann. Trop. Med. Parasitol. 72,
581^582.
[65] Anders, R.F., Roberts-Thomson, I.C. and Mitchell, G.F.
(1982) Giardiasis in mice. Analysis of humoral and cellular
immune response to Giardia muris. Parasite Immunol. 6, 45^
57.
[66] Schlamowitz, M. (1976) Membrane receptors in the speci¢c
transfer of immunoglobulins from mother to young. Immu-
nol. Commun. 5, 481^500.
[67] Goka, A.K.J., Mathan, V.I., Rolston, D.D.K. and Farthing,
M.J.G. (1986) Diagnosis of giardiasis by speci¢c IgM anti-
body by enzyme linked immunosorbent assay. Lancet ii 2,
184^186.
[68] Owen, R.L., Allen, C.L. and Stevens, D.P. (1981) Phagocyto-
sis of Giardia muris by macrophages in Peyer’s patch epithe-
lium in mice. Infect. Immun. 33, 591^601.
FEMSIM 960 8-2-99
H. Kaur et al. / FEMS Immunology and Medical Microbiology 23 (1999) 93^105 105
